Papers - MIKAMI Jotaro
-
Subsequent systemic therapy initiation after first-line discontinuation in metastatic renal cell carcinoma: insights from a Japanese real-world cohort.
Sato H, Narita T, Sekine Y, Shinohara M, Kawashima Y, Mori K, Numakura K, Kodama H, Mikami J, Fujita N, Okamoto T, Yamamoto H, Narita S, Sato S, Habuchi T, Ohyama C, Hatakeyama S
ESMO real world data and digital oncology 13 100733 2026.9
-
Real-world trends in anti-androgen prescribing and associated costs for prostate cancer in Japan: a nationwide analysis
Omizo, S; Narita, T; Hamaya, T; Togashi, K; Ogawa, I; Tazawa, S; Ishimoto, K; Sakao, M; Mikami, J; Fujita, N; Okamoto, T; Imai, A; Yamamoto, H; Ohyama, C; Hatakeyama, S
JAPANESE JOURNAL OF CLINICAL ONCOLOGY 2026.7
-
Real-world Outcomes of Adjuvant Nivolumab in High-risk Bladder and Upper Tract Urothelial Carcinoma after Radical Surgery
Tazawa, S; Shinohara, M; Kawashima, Y; Sekine, Y; Narita, S; Kobayashi, S; Abe, N; Narita, T; Fujita, N; Mikami, J; Okamoto, T; Yamamoto, H; Numakura, K; Sato, S; Habuchi, T; Ohyama, C; Hatakeyama, S
EUROPEAN UROLOGY OPEN SCIENCE 88 90 - 98 2026.6
-
Longitudinal Aortic Calcification and Clinical Outcomes: Hemodialysis vs Living-Donor Kidney Transplantation
Kodama, H; Hamaya, T; Fujita, N; Mikami, J; Okamoto, T; Yamamoto, H; Imai, A; Hatakeyama, S
AMERICAN JOURNAL OF TRANSPLANTATION 26 ( 7 ) S613 - S614 2026.6
-
Donor Aortic Calcification is Associated with 1-Year Graft Function After Living-Donor Kidney Transplantation
Kodama, H; Hamaya, T; Fujita, N; Mikami, J; Okamoto, T; Yamamoto, H; Imai, A; Hatakeyama, S
AMERICAN JOURNAL OF TRANSPLANTATION 26 ( 7 ) S641 - S641 2026.6
-
Development of a Kidney Function Prediction Model for Prognostic Assessment After Kidney Transplantation
Kodama, H; Fujita, N; Hamaya, T; Mikami, J; Okamoto, T; Yamamoto, H; Imai, A; Hatakeyama, S
AMERICAN JOURNAL OF TRANSPLANTATION 26 ( 7 ) S787 - S787 2026.6
-
Visualizing eligibility gaps between muscle-invasive bladder cancer trials and real-world patients
Ichiyama, T; Narita, T; Sekine, Y; Shinohara, M; Kawashima, Y; Kobayashi, M; Numakura, K; Mikami, J; Fujita, N; Okamoto, T; Yamamoto, H; Narita, S; Sato, S; Habuchi, T; Ohyama, C; Hatakeyama, S
JAPANESE JOURNAL OF CLINICAL ONCOLOGY 2026.5
-
CT-based renal artery caliber change as a potential imaging marker of treatment response in renal cell carcinoma; an exploratory imaging study
Asanuma, H; Okamoto, T; Yoshizawa, T; Oishi, T; Hamaya, T; Kodama, H; Narita, T; Mikami, J; Fujita, N; Yoneyama, T; Yamamoto, H; Imai, A; Ohyama, C; Hatakeyama, S
CANCER IMAGING 26 ( 1 ) 2026.3
-
Overactive Bladder Symptoms as a Predictor of Longitudinal Decline in Grip Strength in Community-Dwelling Men: A 4-Year Longitudinal Study
Sato, H; Okamoto, T; Hamaya, T; Kodama, H; Narita, T; Mikami, J; Fujita, N; Yamamoto, H; Imai, A; Murashita, K; Nakaji, S; Hatakeyama, S
LUTS-LOWER URINARY TRACT SYMPTOMS 18 ( 2 ) e70056 2026.3
-
A study on the utility of the Glasgow Prognostic Score (GPS) in treatment selection for metastatic renal cell carcinoma
Yoneyama, F; Kodama, H; Narita, T; Kojima, Y; Mikami, J; Fujita, N; Okamoto, T; Yamamoto, H; Imai, A; Narita, S; Sato, S; Habuchi, T; Ohyama, C; Hatakeyama, S
EUROPEAN UROLOGY 89 2026.3
-
Quantifying the value of tumor response and survival: Perceived monetary loss in anticancer therapy.
Narita, T; Yoneyama, A; Oomizo, S; Kodama, H; Mikami, J; Kojima, Y; Fujita, N; Okamoto, T; Yamamoto, H; Imai, A; Ohyama, C; Hatakeyama, S
JOURNAL OF CLINICAL ONCOLOGY 44 ( 7_SUPPL ) 878 - 878 2026.3
-
Discrepancies in the administration of sequential therapies for metastatic renal cell carcinoma: Real-world practice versus randomized controlled trials
Narita, T; Sekine, Y; Shinohara, M; Kawashima, Y; Mori, K; Kobayashi, M; Sato, H; Numakura, K; Kodama, H; Mikami, J; Fujita, N; Okamoto, T; Yamamoto, H; Narita, S; Sato, S; Habuchi, T; Ohyama, C; Hatakeyama, S
JOURNAL OF CLINICAL ONCOLOGY 44 ( 7_SUPPL ) 2026.3
-
Bridging trial and practice: Real-world data of adjuvant nivolumab in high-risk muscle-invasive urothelial carcinoma.
Narita, T; Tazawa, S; Shinohara, M; Kawashima, Y; Sekine, Y; Narita, S; Kobayashi, S; Abe, N; Fujita, N; Mikami, J; Okamoto, T; Numakura, K; Sato, S; Habuchi, T; Ohyama, C; Hatakeyama, S
JOURNAL OF CLINICAL ONCOLOGY 44 ( 7_SUPPL ) 710 - 710 2026.3
-
Integrated Assessment of Percentage a2,3-Linked Sialylated Prostate-specific Antigen and the Prostate Health Index with Magnetic Resonance Imaging for Detection of Clinically Significant Prostate Cancer
Oishi, T; Yoneyama, T; Miura, Y; Hamaya, T; Kodama, H; Narita, T; Mikami, J; Fujita, N; Okamoto, T; Yamamoto, H; Imai, A; Ohyama, C; Hatakeyama, S
EUROPEAN UROLOGY OPEN SCIENCE 83 158 - 165 2026.1
-
Immediate Postoperative cfDNA Elevation Predicts Pain After Robot-Assisted Radical Prostatectomy
Ishii, N; Yoneyama, T; Minakawa, S; Konishi, S; Kodama, H; Narita, T; Mikami, J; Fujita, N; Okamoto, T; Yamamoto, H; Imai, A; Ohyama, C; Hatakeyama, S
INTERNATIONAL JOURNAL OF UROLOGY 33 ( 1 ) e70297 2026.1
-
Effects of Avelumab Maintenance on Advanced Urothelial Carcinoma: A Real-World Multicenter Study
Ishii, N; Sekine, Y; Shinohara, M; Kawashima, Y; Mori, K; Kobayashi, M; Numakura, K; Mikami, J; Fujita, N; Okamoto, T; Yoneyama, T; Tabata, R; Sato, S; Habuchi, T; Ohyama, C; Hatakeyama, S
CANCER MEDICINE 14 ( 18 ) e71241 2025.9
-
Impact of Skin Adverse Events on Prognosis in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin: A Real-World Multicenter Study
Ozaki, K; Yamamoto, H; Sekine, Y; Horiguchi, H; Hosogoe, S; Mikami, J; Fujita, N; Tokui, N; Okita, K; Okamoto, T; Mori, K; Kobayashi, M; Numakura, K; Yoneyama, T; Tabata, R; Sato, S; Habuchi, T; Ohyama, C; Hatakeyama, S
INTERNATIONAL JOURNAL OF UROLOGY 32 ( 6 ) 679 - 685 2025.6
-
Multicenter, international, retrospective study of prognostic factors for Ra223
Oishi, T; Luo, HL; Hatayama, Y; Kawaguchi, H; Sasaki, D; Tanaka, R; Ishii, N; Mikami, J; Okamoto, T; Yamamoto, H; Aoki, M; Su, YL; Chen, YH; Chang, YH; Chen, YT; Wang, HJ; Ohyama, C; Hatakeyama, S
SCIENTIFIC REPORTS 15 ( 1 ) 10814 2025.3
-
The diversity of BCG adverse events as a predictor of oncological outcomes in patients with non-muscle-invasive bladder cancer: A multicenter retrospective study
Narita, T; Okuyama, Y; Noro, D; Mikami, J; Ishii, N; Ito, H; Soma, O; Fujita, N; Okamoto, T; Yamamoto, H; Ohyama, C; Hatakeyama, S
EUROPEAN UROLOGY 87 2025.3
-
Efficacy and safety of enfortumab vedotin in urothelial carcinoma: A real-world multicenter study
Ozaki, K; Yamamoto, H; Sekine, Y; Horiguchi, H; Hosogoe, S; Mikami, J; Fujita, N; Tokui, N; Okita, K; Okamoto, T; Mori, K; Kobayashi, M; Numakura, K; Yoneyama, T; Tabata, R; Sato, S; Habuchi, T; Ohyama, C; Hatakeyama, S
EUROPEAN UROLOGY 87 2025.3